United Biopharma
Biotechnology ResearchTaiwan11-50 Employees
United Biopharma (UBP) was established in September 2013 as a spinoff of UBI, which originated in the United States in 1985. The company develops, manufactures, and markets integrated therapeutic monoclonal antibody products and related technologies. It also provides fully integrated contract development and manufacturing organization (CDMO) services to support biopharmaceutical programs. UBP operates globally with development, R&D, and manufacturing centers in Taiwan and China, and business centers in the United States and Taiwan. Its client base consists of biopharma and biotech entities seeking end-to-end mAb product development and manufacturing capabilities. Positioned within the biotechnology research industry, UBP functions as an integrated provider spanning product development, manufacturing, and contract services.